MEREDITH COVINGTON: Open Payments
NPI 1821186917 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 29 payments from 11 companies in 2025. Trend: 2023 $1,158 · 2024 $960 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 11 | $177 |
| Boston Scientific Corporation | 1 | $114 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $75 |
| Alnylam Pharmaceuticals Inc. | 3 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Philips North America LLC | 2 | $36 |
| BridgeBio Pharma, Inc. | 2 | $35 |
| Innovation Technologies Inc | 1 | $32 |
| United Therapeutics Corporation | 1 | $32 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
Products named: WATCHMAN Access System, ELIQUIS, VYNDAQEL, JARDIANCE, AMVUTTRA, Kerendia, LM Undivided, Attruby.
Industry payments across MS — which companies pay providers there.
